1-12 of 12
Kate Sasser, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Anti-Tumor Activity of Hexabody-CD38 in Patient-Derived B Cell Lymphoma and Acute Myeloid Leukemia Xenograft Models

Ida H Hiemstra, PhD, Maarten L Janmaat, PhD, Peter Boross, PhD, Jeroen van den Brakel, Wessel ten Hagen, Sanne van Dooremalen, Sieto Bosgra, PhD, Bart ECG De Goeij, PhD, Grietje Andringa, Laurens Kil, PhD, A Kate Sasser, PhD, Tahamtan Ahmadi, MD PhD, David Satijn, PhD, Esther CW Breij, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140313
Published: 2020
Journal Articles

Duohexabody-CD37, a Novel Bispecific Antibody with a Hexamerization-Enhancing Mutation Targeting CD37, Demonstrates Superior Complement-Dependent Cytotoxicity in Preclinical B-Cell Malignancy Models

Simone C. Oostindie, MSc, Hilma J. Van Der Horst, MSc, Marije B. Overdijk, PhD, Kristin Strumane, PhD, Sandra Verploegen, PhD, Margaret A. Lindorfer, PhD, Erica M. Cook, B.A., Martine E.D. Chamuleau, MD, Tuna Mutis, PhD, Janine Schuurman, PhD, A. Kate Sasser, PhD, Ronald P. Taylor, PhD, Paul W. H. I. Parren, PhD, Frank J. Beurskens, PhD, Esther C. W. Breij, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4170.
https://doi.org/10.1182/blood-2018-99-114723
Published: 2018
Journal Articles

Patient Data Supports the Rationale of Low Dose Cyclophosphamide to Potentiate the Anti-Myeloma Activity of Daratumumab through Augmentation of Macrophage-Induced ADCP

Serika Naicker, BSc, PhD, Athina Rigalou, BSc MSc, Cian McEllistrim, MB, BCh, BAO, Alessandro Natoni, PhD, Christopher Chiu, Kate Sasser, PhD, Aideen Ryan, BSc,PhD, Michael O'Dwyer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 121.
https://doi.org/10.1182/blood.V130.Suppl_1.121.121
Published: 2017
Journal Articles

Mass Cytometry As a Modality to Identify Candidates for Immune Checkpoint Inhibitor Therapy within Acute Myeloid Leukemia

Adam Lamble, MD, Yoko Kosaka, PhD, Fei Huang, A Kate Sasser, PhD, Homer Adams, III, PhD, Cristina E. Tognon, Ted Laderas, PhD, Shannon K. McWeeney, Marc M. Loriaux, Jeffrey W. Tyner, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2016) 128 (22): 2829.
https://doi.org/10.1182/blood.V128.22.2829.2829
Published: 2016
Journal Articles

Enhanced VISTA Expression in a Subset of Patients with Acute Myeloid Leukemia

Adam Lamble, MD, Yoko Kosaka, PhD, Fei Huang, A Kate Sasser, PhD, Homer Adams, III, PhD, Cristina E. Tognon, Ted Laderas, PhD, Shannon K. McWeeney, Marc M. Loriaux, Jeffrey W. Tyner, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2016) 128 (22): 4056.
https://doi.org/10.1182/blood.V128.22.4056.4056
Published: 2016
Journal Articles

Potentiation of Anti-Myeloma Activity of Daratumumab with Combination of Cyclophosphamide, Lenalidomide or Bortezomib Via a Tumor Secretory Response That Greatly Augments Macrophage-Induced ADCP

Athina Rigalou, MSc., Aideen Ryan, PhD, Alessandro Natoni, PhD, Christopher Chiu, PhD, Kate Sasser, PhD, Michael E O'Dwyer, MD
Journal: Blood
Blood (2016) 128 (22): 2101.
https://doi.org/10.1182/blood.V128.22.2101.2101
Published: 2016
Journal Articles

Evaluation of Minimal Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients Treated with Daratumumab in Combination with Lenalidomide Plus Dexamethasone or Bortezomib Plus Dexamethasone

Hervé Avet-Loiseau, Tineke Casneuf, Christopher Chiu, PhD, Jacob P. Laubach, MD, Je-Jung Lee, Philippe Moreau, Torben Plesner, Professor, Hareth Nahi, Nushmia Z Khokhar, Ming Qi, Jordan Schecter, Victoria Carlton, PhD, Xiang Qin, Kevin Liu, Kaida Wu, MD PhD, Sen H. Zhuang, MD, PhD, Tahamtan Ahmadi, MD, A. Kate Sasser, PhD, Jesús San-Miguel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 246.
https://doi.org/10.1182/blood.V128.22.246.246
Published: 2016
Journal Articles

Preclinical Evaluation of CSL362/JNJ-56022473 in Combination with Decitabine or Azacitidine in in Vitro Assays

Khaja Syed, M.S., Christine Pietsch, PhD, Amy Axel, Ann Forslund, PhD, Kate Sasser, PhD, Mark Salvati, PhD
Journal: Blood
Blood (2015) 126 (23): 1370.
https://doi.org/10.1182/blood.V126.23.1370.1370
Published: 2015
Journal Articles

Defining the Immune Microenvironment in Patients with Acute Myeloid Leukemia

Adam Lamble, MD, Yoko Kosaka, PhD, Pierrette Lo, MS, Fei Huang, PhD, Kate Sasser, PhD, Cristina E. Tognon, PhD, Marc Loriaux, MD PhD, Jeffrey W. Tyner, PhD, Brian J. Druker, MD, Evan F. Lind, PhD
Journal: Blood
Blood (2015) 126 (23): 1374.
https://doi.org/10.1182/blood.V126.23.1374.1374
Published: 2015
Journal Articles

Preclinical Evaluation of CSL362/JNJ-56022473 Single Agent in in Vitro Assays

Khaja Syed, M.S., Christine Pietsch, PhD, Amy Axel, Ann Forslund, PhD, Kate Sasser, PhD, Mark Salvati, PhD
Journal: Blood
Blood (2015) 126 (23): 4946.
https://doi.org/10.1182/blood.V126.23.4946.4946
Published: 2015
Journal Articles

Generation and Characterization of Microvesicles after Daratumumab Interaction with Myeloma Cells

Antonella Chillemi, PhD, Valeria Quarona, Andrea Zito, Fabio Morandi, PhD, Danilo Marimpietri, Massimiliano Cuccioloni, PhD, Oldham J Robert, Cragg S Mark, PhD, Marina Bolzoni, PhD, Denise Toscani, PhD, Vito Pistoia, MD, Nicola Giuliani, MD PhD, Alberto L Horenstein, PhD, Kate Sasser, PhD, Fabio Malavasi, MD
Journal: Blood
Blood (2015) 126 (23): 1849.
https://doi.org/10.1182/blood.V126.23.1849.1849
Published: 2015
Journal Articles

Development Of a Serum Biomarker Panel That Predicts Imminent Risk Of Multiple Myeloma (MM) Progression From Premalignancy

A Kate Sasser, PhD, Tineke Casneuf, PhD, Dhammika Amaratunga, PhD, Volha Tryputsen, PhD, Shaji K Kumar, MD, Vincent Rajkumar, MD, Brett Hall
Journal: Blood
Blood (2013) 122 (21): 3115.
https://doi.org/10.1182/blood.V122.21.3115.3115
Published: 2013